Global Infections Imaging Services Market By Modalities (X-ray Imaging, Computed Tomography (CT), Magnetic Resonance Imaging (MRI), Ultrasound, Nuclear Medicine Techniques (Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT)) Others) By Indication (Pulmonary Infection (Tuberculosis, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, Asthma, Others) Musculoskeletal Infections (Osteomyelitis, Myositis, Pyomyositis, Septic Arthritis, Abscess, Others) Abdominal and Pelvic Infections, Neurological Infections (Encephalitis, Meningitis, Fungal Infections, Parasitic Infections, Prion Diseases, Others) Kidney Infections, Meningeal Infection, Others) By Age Group (Pediatric, Adults, Geriatric) By Region (North America (U.S., Canada, Mexico, Rest Of North America), Europe (France, The UK, Spain, Germany, Italy, Denmark, Finland, Iceland, Sweden, Norway, Belgium, The Netherlands, Luxembourg, Rest of Europe), Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia, Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia, Rest of Asia Pacific, Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa) Latin America (Brazil, Argentina, Rest of Latin America)) - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast, 2023 – 2031
Global Infections Imaging Services Market Recorded Revenue Worth US$ 90.34 Bn in 2022, Expanding at a CAGR of 5.73% over 2023- 2031.
Infections imaging services encompass a range of diagnostic imaging techniques used to detect and monitor infections in the human body. These services play a crucial role in identifying the presence, location, and severity of infectious diseases, aiding in accurate diagnosis and guiding appropriate treatment strategies. Infections imaging services are typically provided by imaging centers, hospitals, and specialized diagnostic facilities. These services are conducted by trained radiologists and technologists who interpret the imaging studies and collaborate with healthcare professionals to provide accurate diagnoses and treatment recommendations. The utilization of infections imaging services has significantly contributed to the early detection, proper management, and improved outcomes of infectious diseases. Advancements in imaging technologies continue to enhance the capabilities of infections imaging, leading to more precise and targeted diagnoses, as well as improved monitoring of treatment response.
Factors Propelling the Growth of the Global Infections Imaging Services Market
Technological Advancements in Imaging Modalities: Advancements in medical imaging technologies, such as CT, MRI, ultrasound, and molecular imaging, have improved the sensitivity, specificity, and resolution of infections imaging. For example, MRI has undergone advancements that have enhanced infection imaging capabilities. Higher field-strength magnets, such as 3 Tesla (3T) or even 7 Tesla (7T), offer improved signal-to-noise ratio and spatial resolution, allowing for better visualization of infections. Advanced MRI sequences, such as diffusion-weighted imaging (DWI), have proven valuable in detecting and characterizing infections by assessing water diffusion in tissues. These technological advancements enable better detection, characterization, and monitoring of infectious diseases, thereby driving the growth of the infections imaging services market.
Collaboration and Partnerships: Collaborations and partnerships between imaging service providers, healthcare institutions, and pharmaceutical companies are driving advancements in infections imaging. This includes conducting clinical trials to evaluate the efficacy and safety of new imaging techniques and agents for infection imaging. By pooling resources, expertise, and patient populations, these partnerships accelerate the discovery and validation of innovative imaging approaches. Additionally, they facilitate research, development, and implementation of new imaging technologies and techniques, further boosting the growth of the infections imaging services market.
Global Infections imaging Services Market Revenue & Forecast, (US$ Million), 2015 – 2031
Based on the type of imaging, magnetic resonance imaging (MRI) had the highest share in the global infection imaging services market in 2022. Magnetic resonance imaging (MRI) is an effective imaging technique for diagnosing soft tissue, joint, and bone infections in the musculoskeletal (MSK) system. It enables quick identification and evaluation of illness extent, allowing for appropriate therapy to optimise long-term clinical results. The usual features of MSK infections, such as superficial and deep soft tissue oedema, joint, bursal, and tendon sheath effusions, can be detected using MRI. In the upcoming years it is estimated that other infection imaging techniques will go through further advanced innovations leading to the growth of the global infection imaging services market.
North America had the highest share in the infections imaging services market in 2022. Due to the presence of the leading players of the market in United States and Canada as well as advanced healthcare infrastructure is supporting for this growth. Besides government organizations, healthcare institutions are also investing into clinics and centers to offer patients with innovative medical imaging services. Such investments aim to provide patients with access to state-of-the-art diagnostic and imaging technologies for improved detection and management of infections.
Latin America is an emerging region for infection imaging services market. The region's increasing healthcare expenditure, improving healthcare infrastructure, and rising prevalence of infectious diseases contribute for market growth. However, challenges such as limited access to advanced imaging technologies and healthcare disparities in certain areas is likely to impact the market growth to some extent.
Competitive Landscape
The report provides both, qualitative and quantitative research of global infections imaging services market, as well as provides comprehensive insights and development methods adopted by the key contenders. The report also offers extensive research on the key players in this market and details on the competitiveness of these players. Key business strategies such as mergers and acquisitions (M&A), affiliations, collaborations, and contracts adopted by these major market participants are also recognized and analysed in the report. For each company, the report studies their global presence, competitors, service offerings and specification amongst others.
Some of the players operating in the global infections imaging services market are
- Agiliti Health, Inc.
- Akumin Inc
- Alliance MRI
- CMS Diagnostic Services
- InHealth Group
- RadNet, Inc.
- RAYUS Radiology
- SimonMed
- Sonic Healthcare Limited
- Tellica, Inc
- UNILABS
- Other Industry Participants
Global Infections Imaging Services Market
By Modalities
- X-ray imaging
- Computed Tomography (CT)
- Magnetic Resonance Imaging (MRI)
- Ultrasound
- Nuclear Medicine Techniques
- Positron Emission Tomography (PET)
- Single-Photon Emission Computed Tomography (SPECT)
- Others
By Indication
- Pulmonary Infection
- Tuberculosis
- Chronic obstructive pulmonary disease (COPD)
- Cystic fibrosis
- Asthma
- Others
- Musculoskeletal infections
- Osteomyelitis
- Myositis
- Pyomyositis
- Septic Arthritis
- Abscess
- Others
- Abdominal and Pelvic Infections
- Neurological Infections
- Encephalitis
- Meningitis
- Fungal infections
- Parasitic infections
- Prion diseases
- Others
- Kidney Infections
- Meningeal infection
- Others
By Age Group
- Pediatric
- Adults
- Geriatric
By Region
- North America (U.S., Canada, Mexico, Rest of North America)
- Europe (France, The UK, Spain, Germany, Italy, Nordic Countries (Denmark, Finland, Iceland, Sweden, Norway), Benelux Union (Belgium, The Netherlands, Luxembourg), Rest of Europe
- Asia Pacific (China, Japan, India, New Zealand, Australia, South Korea, Southeast Asia (Indonesia, Thailand, Malaysia, Singapore, Rest of Southeast Asia), Rest of Asia Pacific
- Middle East & Africa (Saudi Arabia, UAE, Egypt, Kuwait, South Africa, Rest of Middle East & Africa)
- Latin America (Brazil, Argentina, Rest of Latin America)
Table of Contents
1. Market Scope
1.1. Market
Segmentation
1.2. Years
Considered
1.2.1. Historic
Years: 2015 - 2021
1.2.2. Base
Year: 2022
1.2.3. Forecast
Years: 2023 – 2031
2. Key Target Audiences
3. Research Methodology
3.1. Primary
Research
3.1.1. Research
Questionnaire
3.1.2. Global
Percentage Breakdown
3.1.3. Primary
Interviews: Key Opinion Leaders (KOLs)
3.2. Secondary
Research
3.2.1. Paid
Databases
3.2.2. Secondary
Sources
3.3. Market
Size Estimates
3.3.1. Top-Down
Approach
3.3.2. Bottom-Up
Approach
3.4. Data
Triangulation Methodology
3.5. Research
Assumptions
4. Recommendations and Insights from AMI’s Perspective**
5. Holistic Overview of Infections Imaging Services Market
6. Market Synopsis:
Infections Imaging Services Market
7. Infections Imaging Services Market Analysis: Qualitative
Perspective
7.1. Introduction
7.1.1. Product
Definition
7.1.2. Industry
Development
7.2. Market Dynamics
7.2.1. Drivers
7.2.2. Restraints
7.2.3. Opportunities
7.3. Trends in
Infections Imaging Services Market
7.4. Market
Determinants Radar Chart
7.5. Macro-Economic
and Micro-Economic Indicators: Infections Imaging Services Market
7.6. Porter’s
Five Force Analysis
7.7. Impact of
Covid-19 on Infections Imaging Services Market
8. Global Infections Imaging Services Market Analysis and
Forecasts, 2023 – 2031
8.1. Overview
8.1.1. Global
Infections Imaging Services Market Revenue (US$ Mn)
8.2. Global
Infections Imaging Services Market Revenue (US$ Mn) and Forecasts, By Modalities
8.2.1. X-ray
imaging
8.2.1.1. Definition
8.2.1.2. Market Estimation and Penetration, 2015 - 2022
8.2.1.3. Market Forecast, 2023 - 2031
8.2.1.4. Compound Annual Growth Rate (CAGR)
8.2.1.5. Regional Bifurcation
8.2.1.5.1. North America
8.2.1.5.1.1. Market
Estimation, 2015 - 2022
8.2.1.5.1.2. Market
Forecast, 2023 - 2031
8.2.1.5.2. Europe
8.2.1.5.2.1. Market
Estimation, 2015 - 2022
8.2.1.5.2.2. Market
Forecast, 2023 - 2031
8.2.1.5.3. Asia Pacific
8.2.1.5.3.1. Market
Estimation, 2015 - 2022
8.2.1.5.3.2. Market
Forecast, 2023 - 2031
8.2.1.5.4. Middle East and Africa
8.2.1.5.4.1. Market
Estimation, 2015 - 2022
8.2.1.5.4.2. Market
Forecast, 2023 - 2031
8.2.1.5.5. Latin America
8.2.1.5.5.1. Market
Estimation, 2015 - 2022
8.2.1.5.5.2. Market
Forecast, 2023 - 2031
8.2.2. Computed
Tomography (CT)
8.2.2.1. Definition
8.2.2.2. Market Estimation and Penetration, 2015 - 2022
8.2.2.3. Market Forecast, 2023 - 2031
8.2.2.4. Compound Annual Growth Rate (CAGR)
8.2.2.5. Regional Bifurcation
8.2.2.5.1. North America
8.2.2.5.1.1. Market
Estimation, 2015 - 2022
8.2.2.5.1.2. Market
Forecast, 2023 - 2031
8.2.2.5.2. Europe
8.2.2.5.2.1. Market
Estimation, 2015 - 2022
8.2.2.5.2.2. Market
Forecast, 2023 - 2031
8.2.2.5.3. Asia Pacific
8.2.2.5.3.1. Market
Estimation, 2015 - 2022
8.2.2.5.3.2. Market
Forecast, 2023 - 2031
8.2.2.5.4. Middle East and Africa
8.2.2.5.4.1. Market
Estimation, 2015 - 2022
8.2.2.5.4.2. Market
Forecast, 2023 - 2031
8.2.2.5.5. Latin America
8.2.2.5.5.1. Market
Estimation, 2015 - 2022
8.2.2.5.5.2. Market
Forecast, 2023 - 2031
8.2.3. Magnetic
Resonance Imaging (MRI
8.2.3.1. Definition
8.2.3.2. Market Estimation and Penetration, 2015 - 2022
8.2.3.3. Market Forecast, 2023 - 2031
8.2.3.4. Compound Annual Growth Rate (CAGR)
8.2.3.5. Regional Bifurcation
8.2.3.5.1. North America
8.2.3.5.1.1. Market
Estimation, 2015 - 2022
8.2.3.5.1.2. Market
Forecast, 2023 - 2031
8.2.3.5.2. Europe
8.2.3.5.2.1. Market
Estimation, 2015 - 2022
8.2.3.5.2.2. Market
Forecast, 2023 - 2031
8.2.3.5.3. Asia Pacific
8.2.3.5.3.1. Market
Estimation, 2015 - 2022
8.2.3.5.3.2. Market
Forecast, 2023 - 2031
8.2.3.5.4. Middle East and Africa
8.2.3.5.4.1. Market
Estimation, 2015 - 2022
8.2.3.5.4.2. Market
Forecast, 2023 - 2031
8.2.3.5.5. Latin America
8.2.3.5.5.1. Market
Estimation, 2015 - 2022
8.2.3.5.5.2. Market
Forecast, 2023 - 2031
8.2.4. Ultrasound
8.2.4.1. Definition
8.2.4.2. Market Estimation and Penetration, 2015 - 2022
8.2.4.3. Market Forecast, 2023 - 2031
8.2.4.4. Compound Annual Growth Rate (CAGR)
8.2.4.5. Regional Bifurcation
8.2.4.5.1. North America
8.2.4.5.1.1. Market
Estimation, 2015 - 2022
8.2.4.5.1.2. Market
Forecast, 2023 - 2031
8.2.4.5.2. Europe
8.2.4.5.2.1. Market
Estimation, 2015 - 2022
8.2.4.5.2.2. Market
Forecast, 2023 - 2031
8.2.4.5.3. Asia Pacific
8.2.4.5.3.1. Market
Estimation, 2015 - 2022
8.2.4.5.3.2. Market
Forecast, 2023 - 2031
8.2.4.5.4. Middle East and Africa
8.2.4.5.4.1. Market
Estimation, 2015 - 2022
8.2.4.5.4.2. Market
Forecast, 2023 - 2031
8.2.4.5.5. Latin America
8.2.4.5.5.1. Market
Estimation, 2015 - 2022
8.2.4.5.5.2. Market
Forecast, 2023 - 2031
8.2.5. Nuclear
Medicine Techniques (Definition, Market Estimation and Penetration, 2015 -
2022, Market Estimation (2015 - 2022), Market Forecast(2023 - 2031), Compound
Annual Growth Rate (CAGR), Regional Bifurcation (North America, Europe, Asia
Pacific, Middle East and Africa, Latin America) and Information on Positron
Emission Tomography (PET) , Single-Photon Emission Computed Tomography (SPECT))
8.2.5.1. Positron Emission Tomography (PET)
8.2.5.2. Single-Photon Emission Computed Tomography (SPECT)
8.2.6. Others
8.2.6.1. Definition
8.2.6.2. Market Estimation and Penetration, 2015 - 2022
8.2.6.3. Market Forecast, 2023 - 2031
8.2.6.4. Compound Annual Growth Rate (CAGR)
8.2.6.5. Regional Bifurcation
8.2.6.5.1. North America
8.2.6.5.1.1. Market
Estimation, 2015 - 2022
8.2.6.5.1.2. Market
Forecast, 2023 - 2031
8.2.6.5.2. Europe
8.2.6.5.2.1. Market
Estimation, 2015 - 2022
8.2.6.5.2.2. Market
Forecast, 2023 - 2031
8.2.6.5.3. Asia Pacific
8.2.6.5.3.1. Market
Estimation, 2015 - 2022
8.2.6.5.3.2. Market
Forecast, 2023 - 2031
8.2.6.5.4. Middle East and Africa
8.2.6.5.4.1. Market
Estimation, 2015 - 2022
8.2.6.5.4.2. Market
Forecast, 2023 - 2031
8.2.6.5.5. Latin America
8.2.6.5.5.1. Market
Estimation, 2015 - 2022
8.2.6.5.5.2. Market
Forecast, 2023 - 2031
8.3. Key
Segment for Channeling Investments
8.3.1. By
Modalities
9. Global Infections Imaging Services Market Analysis and
Forecasts, 2023 - 2031
9.1. Overview
9.2. Global
Infections Imaging Services Market Revenue (US$ Mn) and Forecasts, By
Indication
9.2.1. Pulmonary
Infection (Definition, Market Estimation
and Penetration, 2015 - 2022, Market Estimation (2015 - 2022), Market Forecast
(2023 - 2031), Compound Annual Growth Rate (CAGR), Regional Bifurcation (North
America, Europe, Asia Pacific, Middle East and Africa, Latin America) and
Information on Tuberculosis, Chronic obstructive pulmonary disease (COPD),
Cystic fibrosis, Asthma, Others)
9.2.1.1. Tuberculosis
9.2.1.2. Chronic obstructive pulmonary disease (COPD)
9.2.1.3. Cystic fibrosis
9.2.1.4. Asthma
9.2.1.5. Others
9.2.2. Musculoskeletal
Infections (Definition, Market Estimation and Penetration, 2015 - 2022, Market
Estimation (2015 - 2022), Market Forecast(2023 - 2031), Compound Annual Growth
Rate (CAGR), Regional Bifurcation (North America, Europe, Asia Pacific, Middle
East and Africa, Latin America) and Information on Osteomyelitis, Myositis,
Pyomyositis, Septic Arthritis, Abscess, Others )
9.2.2.1. Osteomyelitis
9.2.2.2. Myositis
9.2.2.3. Pyomyositis
9.2.2.4. Septic Arthritis
9.2.2.5. Abscess
9.2.2.6. Others
9.2.3. Abdominal
and Pelvic Infections
9.2.3.1. Definition
9.2.3.2. Market Estimation and Penetration, 2015 - 2022
9.2.3.3. Market Forecast, 2023 - 2031
9.2.3.4. Compound Annual Growth Rate (CAGR)
9.2.3.5. Regional Bifurcation
9.2.3.5.1. North America
9.2.3.5.1.1. Market
Estimation, 2015 - 2022
9.2.3.5.1.2. Market
Forecast, 2023 - 2031
9.2.3.5.2. Europe
9.2.3.5.2.1. Market
Estimation, 2015 - 2022
9.2.3.5.2.2. Market
Forecast, 2023 - 2031
9.2.3.5.3. Asia Pacific
9.2.3.5.3.1. Market
Estimation, 2015 - 2022
9.2.3.5.3.2. Market
Forecast, 2023 - 2031
9.2.3.5.4. Middle East and Africa
9.2.3.5.4.1. Market
Estimation, 2015 - 2022
9.2.3.5.4.2. Market
Forecast, 2023 - 2031
9.2.3.5.5. Latin America
9.2.3.5.5.1. Market
Estimation, 2015 - 2022
9.2.3.5.5.2. Market
Forecast, 2023 - 2031
9.2.4. Neurological
Infections (Definition, Market
Estimation and Penetration, 2015 - 2022, Market Estimation (2015 - 2022),
Market Forecast(2023 - 2031), Compound Annual Growth Rate (CAGR), Regional
Bifurcation (North America, Europe, Asia Pacific, Middle East and Africa, Latin
America) and Information on Encephalitis, Meningitis, Fungal infections,
Parasitic infections, Prion diseases, Others )
9.2.4.1. Encephalitis
9.2.4.2. Meningitis
9.2.4.3. Fungal infections
9.2.4.4. Parasitic infections
9.2.4.5. Prion diseases
9.2.4.6. Others
9.2.5. Kidney
Infections
9.2.5.1. Definition
9.2.5.2. Market Estimation and Penetration, 2015 - 2022
9.2.5.3. Market Forecast, 2023 - 2031
9.2.5.4. Compound Annual Growth Rate (CAGR)
9.2.5.5. Regional Bifurcation
9.2.5.5.1. North America
9.2.5.5.1.1. Market
Estimation, 2015 - 2022
9.2.5.5.1.2. Market
Forecast, 2023 - 2031
9.2.5.5.2. Europe
9.2.5.5.2.1. Market
Estimation, 2015 - 2022
9.2.5.5.2.2. Market
Forecast, 2023 - 2031
9.2.5.5.3. Asia Pacific
9.2.5.5.3.1. Market
Estimation, 2015 - 2022
9.2.5.5.3.2. Market
Forecast, 2023 - 2031
9.2.5.5.4. Middle East and Africa
9.2.5.5.4.1. Market
Estimation, 2015 - 2022
9.2.5.5.4.2. Market
Forecast, 2023 - 2031
9.2.5.5.5. Latin America
9.2.5.5.5.1. Market
Estimation, 2015 - 2022
9.2.5.5.5.2. Market
Forecast, 2023 - 2031
9.2.6. Meningeal
infection
9.2.6.1. Definition
9.2.6.2. Market Estimation and Penetration, 2015 - 2022
9.2.6.3. Market Forecast, 2023 - 2031
9.2.6.4. Compound Annual Growth Rate (CAGR)
9.2.6.5. Regional Bifurcation
9.2.6.5.1. North America
9.2.6.5.1.1. Market
Estimation, 2015 - 2022
9.2.6.5.1.2. Market
Forecast, 2023 - 2031
9.2.6.5.2. Europe
9.2.6.5.2.1. Market
Estimation, 2015 - 2022
9.2.6.5.2.2. Market
Forecast, 2023 - 2031
9.2.6.5.3. Asia Pacific
9.2.6.5.3.1. Market
Estimation, 2015 - 2022
9.2.6.5.3.2. Market
Forecast, 2023 - 2031
9.2.6.5.4. Middle East and Africa
9.2.6.5.4.1. Market
Estimation, 2015 - 2022
9.2.6.5.4.2. Market
Forecast, 2023 - 2031
9.2.6.5.5. Latin America
9.2.6.5.5.1. Market
Estimation, 2015 - 2022
9.2.6.5.5.2. Market
Forecast, 2023 - 2031
9.2.7. Others
9.2.7.1. Definition
9.2.7.2. Market Estimation and Penetration, 2015 - 2022
9.2.7.3. Market Forecast, 2023 - 2031
9.2.7.4. Compound Annual Growth Rate (CAGR)
9.2.7.5. Regional Bifurcation
9.2.7.5.1. North America
9.2.7.5.1.1. Market
Estimation, 2015 - 2022
9.2.7.5.1.2. Market
Forecast, 2023 - 2031
9.2.7.5.2. Europe
9.2.7.5.2.1. Market
Estimation, 2015 - 2022
9.2.7.5.2.2. Market
Forecast, 2023 - 2031
9.2.7.5.3. Asia Pacific
9.2.7.5.3.1. Market
Estimation, 2015 - 2022
9.2.7.5.3.2. Market
Forecast, 2023 - 2031
9.2.7.5.4. Middle East and Africa
9.2.7.5.4.1. Market
Estimation, 2015 - 2022
9.2.7.5.4.2. Market
Forecast, 2023 - 2031
9.2.7.5.5. Latin America
9.2.7.5.5.1. Market
Estimation, 2015 - 2022
9.2.7.5.5.2. Market
Forecast, 2023 - 2031
9.3. Key
Segment for Channeling Investments
9.3.1. By
Indication
10. Global Infections Imaging Services Market Analysis and
Forecasts, 2023 - 2031
10.1. Overview
10.2. Global
Infections Imaging Services Market Revenue (US$ Mn) and Forecasts, By Age Group
10.2.1. Pediatric
10.2.1.1. Definition
10.2.1.2. Market Estimation and Penetration, 2015 - 2022
10.2.1.3. Market Forecast, 2023 - 2031
10.2.1.4. Compound Annual Growth Rate (CAGR)
10.2.1.5. Regional Bifurcation
10.2.1.5.1. North America
10.2.1.5.1.1. Market
Estimation, 2015 - 2022
10.2.1.5.1.2. Market
Forecast, 2023 - 2031
10.2.1.5.2. Europe
10.2.1.5.2.1. Market
Estimation, 2015 - 2022
10.2.1.5.2.2. Market
Forecast, 2023 - 2031
10.2.1.5.3. Asia Pacific
10.2.1.5.3.1. Market
Estimation, 2015 - 2022
10.2.1.5.3.2. Market
Forecast, 2023 - 2031
10.2.1.5.4. Middle East and Africa
10.2.1.5.4.1. Market
Estimation, 2015 - 2022
10.2.1.5.4.2. Market
Forecast, 2023 - 2031
10.2.1.5.5. Latin America
10.2.1.5.5.1. Market
Estimation, 2015 - 2022
10.2.1.5.5.2. Market
Forecast, 2023 - 2031
10.2.2. Adults
10.2.2.1. Definition
10.2.2.2. Market Estimation and Penetration, 2015 - 2022
10.2.2.3. Market Forecast, 2023 - 2031
10.2.2.4. Compound Annual Growth Rate (CAGR)
10.2.2.5. Regional Bifurcation
10.2.2.5.1. North America
10.2.2.5.1.1. Market
Estimation, 2015 - 2022
10.2.2.5.1.2. Market
Forecast, 2023 - 2031
10.2.2.5.2. Europe
10.2.2.5.2.1. Market
Estimation, 2015 - 2022
10.2.2.5.2.2. Market
Forecast, 2023 - 2031
10.2.2.5.3. Asia Pacific
10.2.2.5.3.1. Market
Estimation, 2015 - 2022
10.2.2.5.3.2. Market
Forecast, 2023 - 2031
10.2.2.5.4. Middle East and Africa
10.2.2.5.4.1. Market
Estimation, 2015 - 2022
10.2.2.5.4.2. Market
Forecast, 2023 - 2031
10.2.2.5.5. Latin America
10.2.2.5.5.1. Market
Estimation, 2015 - 2022
10.2.2.5.5.2. Market
Forecast, 2023 - 2031
10.2.3. Geriatric
10.2.3.1. Definition
10.2.3.2. Market Estimation and Penetration, 2015 - 2022
10.2.3.3. Market Forecast, 2023 - 2031
10.2.3.4. Compound Annual Growth Rate (CAGR)
10.2.3.5. Regional Bifurcation
10.2.3.5.1. North America
10.2.3.5.1.1. Market
Estimation, 2015 - 2022
10.2.3.5.1.2. Market
Forecast, 2023 - 2031
10.2.3.5.2. Europe
10.2.3.5.2.1. Market
Estimation, 2015 - 2022
10.2.3.5.2.2. Market
Forecast, 2023 - 2031
10.2.3.5.3. Asia Pacific
10.2.3.5.3.1. Market
Estimation, 2015 - 2022
10.2.3.5.3.2. Market
Forecast, 2023 - 2031
10.2.3.5.4. Middle East and Africa
10.2.3.5.4.1. Market
Estimation, 2015 - 2022
10.2.3.5.4.2. Market
Forecast, 2023 - 2031
10.2.3.5.5. Latin America
10.2.3.5.5.1. Market
Estimation, 2015 - 2022
10.2.3.5.5.2. Market
Forecast, 2023 - 2031
10.3. Key
Segment for Channeling Investments
10.3.1. By Age
Group
11. North America Infections Imaging Services Market Analysis and
Forecasts, 2023 - 2031
11.1. Overview
11.1.1. North
America Infections Imaging Services Market Revenue (US$ Mn)
11.2. North
America Infections Imaging Services Market Revenue (US$ Mn) and Forecasts, By
Modalities
11.2.1. X-ray
imaging
11.2.2. Computed
Tomography (CT)
11.2.3. Magnetic
Resonance Imaging (MRI
11.2.4. Ultrasound
11.2.5. Nuclear
Medicine Techniques
11.2.5.1. Positron Emission Tomography (PET)
11.2.5.2. Single-Photon Emission Computed Tomography (SPECT)
11.2.6. Others
11.3. North
America Infections Imaging Services Market Revenue (US$ Mn) and Forecasts, By
Indication
11.3.1. Pulmonary
Infection
11.3.1.1. Tuberculosis
11.3.1.2. Chronic obstructive pulmonary disease (COPD)
11.3.1.3. Cystic fibrosis
11.3.1.4. Asthma
11.3.1.5. Others
11.3.2. Musculoskeletal
Infections
11.3.2.1. Osteomyelitis
11.3.2.2. Myositis
11.3.2.3. Pyomyositis
11.3.2.4. Septic Arthritis
11.3.2.5. Abscess
11.3.2.6. Others
11.3.3. Abdominal
and Pelvic Infections
11.3.4. Neurological
Infections
11.3.4.1. Encephalitis
11.3.4.2. Meningitis
11.3.4.3. Fungal infections
11.3.4.4. Parasitic infections
11.3.4.5. Prion diseases
11.3.4.6. Others
11.3.5. Kidney
Infections
11.3.6. Meningeal
infection
11.3.7. Others
11.4. North
America Infections Imaging Services Market Revenue (US$ Mn) and Forecasts, By
Age Group
11.4.1. Pediatric
11.4.2. Adults
11.4.3. Geriatric
11.5. North
America Infections Imaging Services Market Revenue (US$ Mn) and Forecasts, By
Country
11.5.1. U.S
11.5.1.1. U.S Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Modalities
11.5.1.1.1. X-ray imaging
11.5.1.1.2. Computed Tomography (CT)
11.5.1.1.3. Magnetic Resonance Imaging (MRI
11.5.1.1.4. Ultrasound
11.5.1.1.5. Nuclear Medicine Techniques
11.5.1.1.5.1. Positron
Emission Tomography (PET)
11.5.1.1.5.2. Single-Photon
Emission Computed Tomography (SPECT)
11.5.1.1.6. Others
11.5.1.2. U.S Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Indication
11.5.1.2.1. Pulmonary Infection
11.5.1.2.1.1. Tuberculosis
11.5.1.2.1.2. Chronic
obstructive pulmonary disease (COPD)
11.5.1.2.1.3. Cystic
fibrosis
11.5.1.2.1.4. Asthma
11.5.1.2.1.5. Others
11.5.1.2.2. Musculoskeletal Infections
11.5.1.2.2.1. Osteomyelitis
11.5.1.2.2.2. Myositis
11.5.1.2.2.3. Pyomyositis
11.5.1.2.2.4. Septic
Arthritis
11.5.1.2.2.5. Abscess
11.5.1.2.2.6. Others
11.5.1.2.3. Abdominal and Pelvic Infections
11.5.1.2.4. Neurological Infections
11.5.1.2.4.1. Encephalitis
11.5.1.2.4.2. Meningitis
11.5.1.2.4.3. Fungal
infections
11.5.1.2.4.4. Parasitic
infections
11.5.1.2.4.5. Prion
diseases
11.5.1.2.4.6. Others
11.5.1.2.5. Kidney Infections
11.5.1.2.6. Meningeal infection
11.5.1.2.7. Others
11.5.1.3. U.S Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Age Group
11.5.1.3.1. Pediatric
11.5.1.3.2. Adults
11.5.1.3.3. Geriatric
11.5.2. Canada
11.5.2.1. Canada Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Modalities
11.5.2.1.1. X-ray imaging
11.5.2.1.2. Computed Tomography (CT)
11.5.2.1.3. Magnetic Resonance Imaging (MRI
11.5.2.1.4. Ultrasound
11.5.2.1.5. Nuclear Medicine Techniques
11.5.2.1.5.1. Positron
Emission Tomography (PET)
11.5.2.1.5.2. Single-Photon
Emission Computed Tomography (SPECT)
11.5.2.1.6. Others
11.5.2.2. Canada Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Indication
11.5.2.2.1. Pulmonary Infection
11.5.2.2.1.1. Tuberculosis
11.5.2.2.1.2. Chronic
obstructive pulmonary disease (COPD)
11.5.2.2.1.3. Cystic
fibrosis
11.5.2.2.1.4. Asthma
11.5.2.2.1.5. Others
11.5.2.2.2. Musculoskeletal Infections
11.5.2.2.2.1. Osteomyelitis
11.5.2.2.2.2. Myositis
11.5.2.2.2.3. Pyomyositis
11.5.2.2.2.4. Septic
Arthritis
11.5.2.2.2.5. Abscess
11.5.2.2.2.6. Others
11.5.2.2.3. Abdominal and Pelvic Infections
11.5.2.2.4. Neurological Infections
11.5.2.2.4.1. Encephalitis
11.5.2.2.4.2. Meningitis
11.5.2.2.4.3. Fungal
infections
11.5.2.2.4.4. Parasitic
infections
11.5.2.2.4.5. Prion
diseases
11.5.2.2.4.6. Others
11.5.2.2.5. Kidney Infections
11.5.2.2.6. Meningeal infection
11.5.2.2.7. Others
11.5.2.3. Canada Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Age Group
11.5.2.3.1. Pediatric
11.5.2.3.2. Adults
11.5.2.3.3. Geriatric
11.5.3. Mexico
11.5.3.1. Mexico Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Modalities
11.5.3.1.1. X-ray imaging
11.5.3.1.2. Computed Tomography (CT)
11.5.3.1.3. Magnetic Resonance Imaging (MRI
11.5.3.1.4. Ultrasound
11.5.3.1.5. Nuclear Medicine Techniques
11.5.3.1.5.1. Positron
Emission Tomography (PET)
11.5.3.1.5.2. Single-Photon
Emission Computed Tomography (SPECT)
11.5.3.1.6. Others
11.5.3.2. Mexico Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Indication
11.5.3.2.1. Pulmonary Infection
11.5.3.2.1.1. Tuberculosis
11.5.3.2.1.2. Chronic
obstructive pulmonary disease (COPD)
11.5.3.2.1.3. Cystic
fibrosis
11.5.3.2.1.4. Asthma
11.5.3.2.1.5. Others
11.5.3.2.2. Musculoskeletal Infections
11.5.3.2.2.1. Osteomyelitis
11.5.3.2.2.2. Myositis
11.5.3.2.2.3. Pyomyositis
11.5.3.2.2.4. Septic
Arthritis
11.5.3.2.2.5. Abscess
11.5.3.2.2.6. Others
11.5.3.2.3. Abdominal and Pelvic Infections
11.5.3.2.4. Neurological Infections
11.5.3.2.4.1. Encephalitis
11.5.3.2.4.2. Meningitis
11.5.3.2.4.3. Fungal
infections
11.5.3.2.4.4. Parasitic
infections
11.5.3.2.4.5. Prion
diseases
11.5.3.2.4.6. Others
11.5.3.2.5. Kidney Infections
11.5.3.2.6. Meningeal infection
11.5.3.2.7. Others
11.5.3.3. Mexico Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Age Group
11.5.3.3.1. Pediatric
11.5.3.3.2. Adults
11.5.3.3.3. Geriatric
11.5.4. Rest of
North America
11.5.4.1. Rest of North America Infections Imaging Services Market
Revenue (US$ Mn) and Forecasts, By Modalities
11.5.4.1.1. X-ray imaging
11.5.4.1.2. Computed Tomography (CT)
11.5.4.1.3. Magnetic Resonance Imaging (MRI
11.5.4.1.4. Ultrasound
11.5.4.1.5. Nuclear Medicine Techniques
11.5.4.1.5.1. Positron
Emission Tomography (PET)
11.5.4.1.5.2. Single-Photon
Emission Computed Tomography (SPECT)
11.5.4.1.6. Others
11.5.4.2. Rest of North America Infections Imaging Services Market
Revenue (US$ Mn) and Forecasts, By Indication
11.5.4.2.1. Pulmonary Infection
11.5.4.2.1.1. Tuberculosis
11.5.4.2.1.2. Chronic
obstructive pulmonary disease (COPD)
11.5.4.2.1.3. Cystic
fibrosis
11.5.4.2.1.4. Asthma
11.5.4.2.1.5. Others
11.5.4.2.2. Musculoskeletal Infections
11.5.4.2.2.1. Osteomyelitis
11.5.4.2.2.2. Myositis
11.5.4.2.2.3. Pyomyositis
11.5.4.2.2.4. Septic
Arthritis
11.5.4.2.2.5. Abscess
11.5.4.2.2.6. Others
11.5.4.2.3. Abdominal and Pelvic Infections
11.5.4.2.4. Neurological Infections
11.5.4.2.4.1. Encephalitis
11.5.4.2.4.2. Meningitis
11.5.4.2.4.3. Fungal
infections
11.5.4.2.4.4. Parasitic
infections
11.5.4.2.4.5. Prion
diseases
11.5.4.2.4.6. Others
11.5.4.2.5. Kidney Infections
11.5.4.2.6. Meningeal infection
11.5.4.2.7. Others
11.5.4.3. Rest of North America Infections Imaging Services Market
Revenue (US$ Mn) and Forecasts, By Age Group
11.5.4.3.1. Pediatric
11.5.4.3.2. Adults
11.5.4.3.3. Geriatric
11.6. Key
Segment for Channeling Investments
11.6.1. By
Country
11.6.2. By
Modalities
11.6.3. By
Indication
11.6.4. By Age
Group
12. Europe Infections Imaging Services Market Analysis and
Forecasts, 2023 - 2031
12.1. Overview
12.1.1. Europe
Infections Imaging Services Market Revenue (US$ Mn)
12.2. Europe
Infections Imaging Services Market Revenue (US$ Mn) and Forecasts, By
Modalities
12.2.1. X-ray
imaging
12.2.2. Computed
Tomography (CT)
12.2.3. Magnetic
Resonance Imaging (MRI
12.2.4. Ultrasound
12.2.5. Nuclear
Medicine Techniques
12.2.5.1. Positron Emission Tomography (PET)
12.2.5.2. Single-Photon Emission Computed Tomography (SPECT)
12.2.6. Others
12.3. Europe
Infections Imaging Services Market Revenue (US$ Mn) and Forecasts, By
Indication
12.3.1. Pulmonary
Infection
12.3.1.1. Tuberculosis
12.3.1.2. Chronic obstructive pulmonary disease (COPD)
12.3.1.3. Cystic fibrosis
12.3.1.4. Asthma
12.3.1.5. Others
12.3.2. Musculoskeletal
Infections
12.3.2.1. Osteomyelitis
12.3.2.2. Myositis
12.3.2.3. Pyomyositis
12.3.2.4. Septic Arthritis
12.3.2.5. Abscess
12.3.2.6. Others
12.3.3. Abdominal
and Pelvic Infections
12.3.4. Neurological
Infections
12.3.4.1. Encephalitis
12.3.4.2. Meningitis
12.3.4.3. Fungal infections
12.3.4.4. Parasitic infections
12.3.4.5. Prion diseases
12.3.4.6. Others
12.3.5. Kidney
Infections
12.3.6. Meningeal
infection
12.3.7. Others
12.4. Europe
Infections Imaging Services Market Revenue (US$ Mn) and Forecasts, By Age Group
12.4.1. Pediatric
12.4.2. Adults
12.4.3. Geriatric
12.5. Europe
Infections Imaging Services Market Revenue (US$ Mn) and Forecasts, By Country
12.5.1. France
12.5.1.1. France Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Modalities
12.5.1.1.1. X-ray imaging
12.5.1.1.2. Computed Tomography (CT)
12.5.1.1.3. Magnetic Resonance Imaging (MRI
12.5.1.1.4. Ultrasound
12.5.1.1.5. Nuclear Medicine Techniques
12.5.1.1.5.1. Positron
Emission Tomography (PET)
12.5.1.1.5.2. Single-Photon
Emission Computed Tomography (SPECT)
12.5.1.1.6. Others
12.5.1.2. France Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Indication
12.5.1.2.1. Pulmonary Infection
12.5.1.2.1.1. Tuberculosis
12.5.1.2.1.2. Chronic
obstructive pulmonary disease (COPD)
12.5.1.2.1.3. Cystic
fibrosis
12.5.1.2.1.4. Asthma
12.5.1.2.1.5. Others
12.5.1.2.2. Musculoskeletal Infections
12.5.1.2.2.1. Osteomyelitis
12.5.1.2.2.2. Myositis
12.5.1.2.2.3. Pyomyositis
12.5.1.2.2.4. Septic
Arthritis
12.5.1.2.2.5. Abscess
12.5.1.2.2.6. Others
12.5.1.2.3. Abdominal and Pelvic Infections
12.5.1.2.4. Neurological Infections
12.5.1.2.4.1. Encephalitis
12.5.1.2.4.2. Meningitis
12.5.1.2.4.3. Fungal
infections
12.5.1.2.4.4. Parasitic
infections
12.5.1.2.4.5. Prion
diseases
12.5.1.2.4.6. Others
12.5.1.2.5. Kidney Infections
12.5.1.2.6. Meningeal infection
12.5.1.2.7. Others
12.5.1.3. France Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Age Group
12.5.1.3.1. Pediatric
12.5.1.3.2. Adults
12.5.1.3.3. Geriatric
12.5.2. The UK
12.5.2.1. The UK Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Modalities
12.5.2.1.1. X-ray imaging
12.5.2.1.2. Computed Tomography (CT)
12.5.2.1.3. Magnetic Resonance Imaging (MRI
12.5.2.1.4. Ultrasound
12.5.2.1.5. Nuclear Medicine Techniques
12.5.2.1.5.1. Positron
Emission Tomography (PET)
12.5.2.1.5.2. Single-Photon
Emission Computed Tomography (SPECT)
12.5.2.1.6. Others
12.5.2.2. The UK Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Indication
12.5.2.2.1. Pulmonary Infection
12.5.2.2.1.1. Tuberculosis
12.5.2.2.1.2. Chronic
obstructive pulmonary disease (COPD)
12.5.2.2.1.3. Cystic
fibrosis
12.5.2.2.1.4. Asthma
12.5.2.2.1.5. Others
12.5.2.2.2. Musculoskeletal Infections
12.5.2.2.2.1. Osteomyelitis
12.5.2.2.2.2. Myositis
12.5.2.2.2.3. Pyomyositis
12.5.2.2.2.4. Septic
Arthritis
12.5.2.2.2.5. Abscess
12.5.2.2.2.6. Others
12.5.2.2.3. Abdominal and Pelvic Infections
12.5.2.2.4. Neurological Infections
12.5.2.2.4.1. Encephalitis
12.5.2.2.4.2. Meningitis
12.5.2.2.4.3. Fungal
infections
12.5.2.2.4.4. Parasitic
infections
12.5.2.2.4.5. Prion
diseases
12.5.2.2.4.6. Others
12.5.2.2.5. Kidney Infections
12.5.2.2.6. Meningeal infection
12.5.2.2.7. Others
12.5.2.3. The UK Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Age Group
12.5.2.3.1. Pediatric
12.5.2.3.2. Adults
12.5.2.3.3. Geriatric
12.5.3. Spain
12.5.3.1. Spain Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Modalities
12.5.3.1.1. X-ray imaging
12.5.3.1.2. Computed Tomography (CT)
12.5.3.1.3. Magnetic Resonance Imaging (MRI
12.5.3.1.4. Ultrasound
12.5.3.1.5. Nuclear Medicine Techniques
12.5.3.1.5.1. Positron
Emission Tomography (PET)
12.5.3.1.5.2. Single-Photon
Emission Computed Tomography (SPECT)
12.5.3.1.6. Others
12.5.3.2. Spain Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Indication
12.5.3.2.1. Pulmonary Infection
12.5.3.2.1.1. Tuberculosis
12.5.3.2.1.2. Chronic
obstructive pulmonary disease (COPD)
12.5.3.2.1.3. Cystic
fibrosis
12.5.3.2.1.4. Asthma
12.5.3.2.1.5. Others
12.5.3.2.2. Musculoskeletal Infections
12.5.3.2.2.1. Osteomyelitis
12.5.3.2.2.2. Myositis
12.5.3.2.2.3. Pyomyositis
12.5.3.2.2.4. Septic
Arthritis
12.5.3.2.2.5. Abscess
12.5.3.2.2.6. Others
12.5.3.2.3. Abdominal and Pelvic Infections
12.5.3.2.4. Neurological Infections
12.5.3.2.4.1. Encephalitis
12.5.3.2.4.2. Meningitis
12.5.3.2.4.3. Fungal
infections
12.5.3.2.4.4. Parasitic
infections
12.5.3.2.4.5. Prion
diseases
12.5.3.2.4.6. Others
12.5.3.2.5. Kidney Infections
12.5.3.2.6. Meningeal infection
12.5.3.2.7. Others
12.5.3.3. Spain Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Age Group
12.5.3.3.1. Pediatric
12.5.3.3.2. Adults
12.5.3.3.3. Geriatric
12.5.4. Germany
12.5.4.1. Germany Infections Imaging Services Market Revenue (US$ Mn)
and Forecasts, By Modalities
12.5.4.1.1. X-ray imaging
12.5.4.1.2. Computed Tomography (CT)
12.5.4.1.3. Magnetic Resonance Imaging (MRI
12.5.4.1.4. Ultrasound
12.5.4.1.5. Nuclear Medicine Techniques
12.5.4.1.5.1. Positron
Emission Tomography (PET)
12.5.4.1.5.2. Single-Photon
Emission Computed Tomography (SPECT)
12.5.4.1.6. Others
12.5.4.2. Germany Infections Imaging Services Market Revenue (US$ Mn)
and Forecasts, By Indication
12.5.4.2.1. Pulmonary Infection
12.5.4.2.1.1. Tuberculosis
12.5.4.2.1.2. Chronic
obstructive pulmonary disease (COPD)
12.5.4.2.1.3. Cystic
fibrosis
12.5.4.2.1.4. Asthma
12.5.4.2.1.5. Others
12.5.4.2.2. Musculoskeletal Infections
12.5.4.2.2.1. Osteomyelitis
12.5.4.2.2.2. Myositis
12.5.4.2.2.3. Pyomyositis
12.5.4.2.2.4. Septic
Arthritis
12.5.4.2.2.5. Abscess
12.5.4.2.2.6. Others
12.5.4.2.3. Abdominal and Pelvic Infections
12.5.4.2.4. Neurological Infections
12.5.4.2.4.1. Encephalitis
12.5.4.2.4.2. Meningitis
12.5.4.2.4.3. Fungal
infections
12.5.4.2.4.4. Parasitic
infections
12.5.4.2.4.5. Prion
diseases
12.5.4.2.4.6. Others
12.5.4.2.5. Kidney Infections
12.5.4.2.6. Meningeal infection
12.5.4.2.7. Others
12.5.4.3. Germany Infections Imaging Services Market Revenue (US$ Mn)
and Forecasts, By Age Group
12.5.4.3.1. Pediatric
12.5.4.3.2. Adults
12.5.4.3.3. Geriatric
12.5.5. Italy
12.5.5.1. Italy Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Modalities
12.5.5.1.1. X-ray imaging
12.5.5.1.2. Computed Tomography (CT)
12.5.5.1.3. Magnetic Resonance Imaging (MRI
12.5.5.1.4. Ultrasound
12.5.5.1.5. Nuclear Medicine Techniques
12.5.5.1.5.1. Positron
Emission Tomography (PET)
12.5.5.1.5.2. Single-Photon
Emission Computed Tomography (SPECT)
12.5.5.1.6. Others
12.5.5.2. Italy Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Indication
12.5.5.2.1. Pulmonary Infection
12.5.5.2.1.1. Tuberculosis
12.5.5.2.1.2. Chronic
obstructive pulmonary disease (COPD)
12.5.5.2.1.3. Cystic
fibrosis
12.5.5.2.1.4. Asthma
12.5.5.2.1.5. Others
12.5.5.2.2. Musculoskeletal Infections
12.5.5.2.2.1. Osteomyelitis
12.5.5.2.2.2. Myositis
12.5.5.2.2.3. Pyomyositis
12.5.5.2.2.4. Septic
Arthritis
12.5.5.2.2.5. Abscess
12.5.5.2.2.6. Others
12.5.5.2.3. Abdominal and Pelvic Infections
12.5.5.2.4. Neurological Infections
12.5.5.2.4.1. Encephalitis
12.5.5.2.4.2. Meningitis
12.5.5.2.4.3. Fungal
infections
12.5.5.2.4.4. Parasitic
infections
12.5.5.2.4.5. Prion
diseases
12.5.5.2.4.6. Others
12.5.5.2.5. Kidney Infections
12.5.5.2.6. Meningeal infection
12.5.5.2.7. Others
12.5.5.3. Italy Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Age Group
12.5.5.3.1. Pediatric
12.5.5.3.2. Adults
12.5.5.3.3. Geriatric
12.5.6. Nordic
Countries
12.5.6.1. Nordic Countries Infections Imaging Services Market Revenue
(US$ Mn) and Forecasts, By Modalities
12.5.6.1.1. X-ray imaging
12.5.6.1.2. Computed Tomography (CT)
12.5.6.1.3. Magnetic Resonance Imaging (MRI
12.5.6.1.4. Ultrasound
12.5.6.1.5. Nuclear Medicine Techniques
12.5.6.1.5.1. Positron
Emission Tomography (PET)
12.5.6.1.5.2. Single-Photon
Emission Computed Tomography (SPECT)
12.5.6.1.6. Others
12.5.6.2. Nordic Countries Infections Imaging Services Market Revenue
(US$ Mn) and Forecasts, By Indication
12.5.6.2.1. Pulmonary Infection
12.5.6.2.1.1. Tuberculosis
12.5.6.2.1.2. Chronic
obstructive pulmonary disease (COPD)
12.5.6.2.1.3. Cystic
fibrosis
12.5.6.2.1.4. Asthma
12.5.6.2.1.5. Others
12.5.6.2.2. Musculoskeletal Infections
12.5.6.2.2.1. Osteomyelitis
12.5.6.2.2.2. Myositis
12.5.6.2.2.3. Pyomyositis
12.5.6.2.2.4. Septic
Arthritis
12.5.6.2.2.5. Abscess
12.5.6.2.2.6. Others
12.5.6.2.3. Abdominal and Pelvic Infections
12.5.6.2.4. Neurological Infections
12.5.6.2.4.1. Encephalitis
12.5.6.2.4.2. Meningitis
12.5.6.2.4.3. Fungal
infections
12.5.6.2.4.4. Parasitic
infections
12.5.6.2.4.5. Prion
diseases
12.5.6.2.4.6. Others
12.5.6.2.5. Kidney Infections
12.5.6.2.6. Meningeal infection
12.5.6.2.7. Others
12.5.6.3. Nordic Countries Infections Imaging Services Market Revenue
(US$ Mn) and Forecasts, By Age Group
12.5.6.3.1. Pediatric
12.5.6.3.2. Adults
12.5.6.3.3. Geriatric
12.5.6.4. Nordic Countries Infections Imaging Services Market Revenue
(US$ Mn) and Forecasts, By Country
12.5.6.4.1. Denmark
12.5.6.4.2. Finland
12.5.6.4.3. Iceland
12.5.6.4.4. Sweden
12.5.6.4.5. Norway
12.5.7. Benelux
Union
12.5.7.1. Benelux Union Infections Imaging Services Market Revenue (US$
Mn) and Forecasts, By Modalities
12.5.7.1.1. X-ray imaging
12.5.7.1.2. Computed Tomography (CT)
12.5.7.1.3. Magnetic Resonance Imaging (MRI
12.5.7.1.4. Ultrasound
12.5.7.1.5. Nuclear Medicine Techniques
12.5.7.1.5.1. Positron
Emission Tomography (PET)
12.5.7.1.5.2. Single-Photon
Emission Computed Tomography (SPECT)
12.5.7.1.6. Others
12.5.7.2. Benelux Union Infections Imaging Services Market Revenue (US$
Mn) and Forecasts, By Indication
12.5.7.2.1. Pulmonary Infection
12.5.7.2.1.1. Tuberculosis
12.5.7.2.1.2. Chronic
obstructive pulmonary disease (COPD)
12.5.7.2.1.3. Cystic
fibrosis
12.5.7.2.1.4. Asthma
12.5.7.2.1.5. Others
12.5.7.2.2. Musculoskeletal Infections
12.5.7.2.2.1. Osteomyelitis
12.5.7.2.2.2. Myositis
12.5.7.2.2.3. Pyomyositis
12.5.7.2.2.4. Septic
Arthritis
12.5.7.2.2.5. Abscess
12.5.7.2.2.6. Others
12.5.7.2.3. Abdominal and Pelvic Infections
12.5.7.2.4. Neurological Infections
12.5.7.2.4.1. Encephalitis
12.5.7.2.4.2. Meningitis
12.5.7.2.4.3. Fungal
infections
12.5.7.2.4.4. Parasitic
infections
12.5.7.2.4.5. Prion
diseases
12.5.7.2.4.6. Others
12.5.7.2.5. Kidney Infections
12.5.7.2.6. Meningeal infection
12.5.7.2.7. Others
12.5.7.3. Benelux Union Infections Imaging Services Market Revenue (US$
Mn) and Forecasts, By Age Group
12.5.7.3.1. Pediatric
12.5.7.3.2. Adults
12.5.7.3.3. Geriatric
12.5.7.4. Benelux Union Infections Imaging Services Market Revenue (US$
Mn) and Forecasts, By Country
12.5.7.4.1. Belgium
12.5.7.4.2. The Netherlands
12.5.7.4.3. Luxembourg
12.5.8. Rest of
Europe
12.5.8.1. Rest of Europe Infections Imaging Services Market Revenue (US$
Mn) and Forecasts, By Modalities
12.5.8.1.1. X-ray imaging
12.5.8.1.2. Computed Tomography (CT)
12.5.8.1.3. Magnetic Resonance Imaging (MRI
12.5.8.1.4. Ultrasound
12.5.8.1.5. Nuclear Medicine Techniques
12.5.8.1.5.1. Positron
Emission Tomography (PET)
12.5.8.1.5.2. Single-Photon
Emission Computed Tomography (SPECT)
12.5.8.1.6. Others
12.5.8.2. Rest of Europe Infections Imaging Services Market Revenue (US$
Mn) and Forecasts, By Indication
12.5.8.2.1. Pulmonary Infection
12.5.8.2.1.1. Tuberculosis
12.5.8.2.1.2. Chronic
obstructive pulmonary disease (COPD)
12.5.8.2.1.3. Cystic
fibrosis
12.5.8.2.1.4. Asthma
12.5.8.2.1.5. Others
12.5.8.2.2. Musculoskeletal Infections
12.5.8.2.2.1. Osteomyelitis
12.5.8.2.2.2. Myositis
12.5.8.2.2.3. Pyomyositis
12.5.8.2.2.4. Septic
Arthritis
12.5.8.2.2.5. Abscess
12.5.8.2.2.6. Others
12.5.8.2.3. Abdominal and Pelvic Infections
12.5.8.2.4. Neurological Infections
12.5.8.2.4.1. Encephalitis
12.5.8.2.4.2. Meningitis
12.5.8.2.4.3. Fungal
infections
12.5.8.2.4.4. Parasitic
infections
12.5.8.2.4.5. Prion
diseases
12.5.8.2.4.6. Others
12.5.8.2.5. Kidney Infections
12.5.8.2.6. Meningeal infection
12.5.8.2.7. Others
12.5.8.3. Rest of Europe Infections Imaging Services Market Revenue (US$
Mn) and Forecasts, By Age Group
12.5.8.3.1. Pediatric
12.5.8.3.2. Adults
12.5.8.3.3. Geriatric
12.6. Key
Segment for Channeling Investments
12.6.1. By
Country
12.6.2. By
Modalities
12.6.3. By
Indication
12.6.4. By Age
Group
13. Asia Pacific Infections Imaging Services Market Analysis and
Forecasts, 2023 - 2031
13.1. Overview
13.1.1. Asia
Pacific Infections Imaging Services Market Revenue (US$ Mn)
13.2. Asia
Pacific Infections Imaging Services Market Revenue (US$ Mn) and Forecasts, By
Modalities
13.2.1. X-ray
imaging
13.2.2. Computed
Tomography (CT)
13.2.3. Magnetic
Resonance Imaging (MRI
13.2.4. Ultrasound
13.2.5. Nuclear
Medicine Techniques
13.2.5.1. Positron Emission Tomography (PET)
13.2.5.2. Single-Photon Emission Computed Tomography (SPECT)
13.2.6. Others
13.3. Asia
Pacific Infections Imaging Services Market Revenue (US$ Mn) and Forecasts, By
Indication
13.3.1. Pulmonary
Infection
13.3.1.1. Tuberculosis
13.3.1.2. Chronic obstructive pulmonary disease (COPD)
13.3.1.3. Cystic fibrosis
13.3.1.4. Asthma
13.3.1.5. Others
13.3.2. Musculoskeletal
Infections
13.3.2.1. Osteomyelitis
13.3.2.2. Myositis
13.3.2.3. Pyomyositis
13.3.2.4. Septic Arthritis
13.3.2.5. Abscess
13.3.2.6. Others
13.3.3. Abdominal
and Pelvic Infections
13.3.4. Neurological
Infections
13.3.4.1. Encephalitis
13.3.4.2. Meningitis
13.3.4.3. Fungal infections
13.3.4.4. Parasitic infections
13.3.4.5. Prion diseases
13.3.4.6. Others
13.3.5. Kidney
Infections
13.3.6. Meningeal
infection
13.3.7. Others
13.4. Asia
Pacific Infections Imaging Services Market Revenue (US$ Mn) and Forecasts, By
Age Group
13.4.1. Pediatric
13.4.2. Adults
13.4.3. Geriatric
13.5. Asia
Pacific Infections Imaging Services Market Revenue (US$ Mn) and Forecasts, By
Country
13.5.1. China
13.5.1.1. China Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Modalities
13.5.1.1.1. X-ray imaging
13.5.1.1.2. Computed Tomography (CT)
13.5.1.1.3. Magnetic Resonance Imaging (MRI
13.5.1.1.4. Ultrasound
13.5.1.1.5. Nuclear Medicine Techniques
13.5.1.1.5.1. Positron
Emission Tomography (PET)
13.5.1.1.5.2. Single-Photon
Emission Computed Tomography (SPECT)
13.5.1.1.6. Others
13.5.1.2. China Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Indication
13.5.1.2.1. Pulmonary Infection
13.5.1.2.1.1. Tuberculosis
13.5.1.2.1.2. Chronic
obstructive pulmonary disease (COPD)
13.5.1.2.1.3. Cystic
fibrosis
13.5.1.2.1.4. Asthma
13.5.1.2.1.5. Others
13.5.1.2.2. Musculoskeletal Infections
13.5.1.2.2.1. Osteomyelitis
13.5.1.2.2.2. Myositis
13.5.1.2.2.3. Pyomyositis
13.5.1.2.2.4. Septic
Arthritis
13.5.1.2.2.5. Abscess
13.5.1.2.2.6. Others
13.5.1.2.3. Abdominal and Pelvic Infections
13.5.1.2.4. Neurological Infections
13.5.1.2.4.1. Encephalitis
13.5.1.2.4.2. Meningitis
13.5.1.2.4.3. Fungal
infections
13.5.1.2.4.4. Parasitic
infections
13.5.1.2.4.5. Prion
diseases
13.5.1.2.4.6. Others
13.5.1.2.5. Kidney Infections
13.5.1.2.6. Meningeal infection
13.5.1.2.7. Others
13.5.1.3. China Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Age Group
13.5.1.3.1. Pediatric
13.5.1.3.2. Adults
13.5.1.3.3. Geriatric
13.5.2. Japan
13.5.2.1. Japan Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Modalities
13.5.2.1.1. X-ray imaging
13.5.2.1.2. Computed Tomography (CT)
13.5.2.1.3. Magnetic Resonance Imaging (MRI
13.5.2.1.4. Ultrasound
13.5.2.1.5. Nuclear Medicine Techniques
13.5.2.1.5.1. Positron
Emission Tomography (PET)
13.5.2.1.5.2. Single-Photon
Emission Computed Tomography (SPECT)
13.5.2.1.6. Others
13.5.2.2. Japan Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Indication
13.5.2.2.1. Pulmonary Infection
13.5.2.2.1.1. Tuberculosis
13.5.2.2.1.2. Chronic
obstructive pulmonary disease (COPD)
13.5.2.2.1.3. Cystic
fibrosis
13.5.2.2.1.4. Asthma
13.5.2.2.1.5. Others
13.5.2.2.2. Musculoskeletal Infections
13.5.2.2.2.1. Osteomyelitis
13.5.2.2.2.2. Myositis
13.5.2.2.2.3. Pyomyositis
13.5.2.2.2.4. Septic
Arthritis
13.5.2.2.2.5. Abscess
13.5.2.2.2.6. Others
13.5.2.2.3. Abdominal and Pelvic Infections
13.5.2.2.4. Neurological Infections
13.5.2.2.4.1. Encephalitis
13.5.2.2.4.2. Meningitis
13.5.2.2.4.3. Fungal
infections
13.5.2.2.4.4. Parasitic
infections
13.5.2.2.4.5. Prion
diseases
13.5.2.2.4.6. Others
13.5.2.2.5. Kidney Infections
13.5.2.2.6. Meningeal infection
13.5.2.2.7. Others
13.5.2.3. Japan Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Age Group
13.5.2.3.1. Pediatric
13.5.2.3.2. Adults
13.5.2.3.3. Geriatric
13.5.3. India
13.5.3.1. India Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Modalities
13.5.3.1.1. X-ray imaging
13.5.3.1.2. Computed Tomography (CT)
13.5.3.1.3. Magnetic Resonance Imaging (MRI
13.5.3.1.4. Ultrasound
13.5.3.1.5. Nuclear Medicine Techniques
13.5.3.1.5.1. Positron
Emission Tomography (PET)
13.5.3.1.5.2. Single-Photon
Emission Computed Tomography (SPECT)
13.5.3.1.6. Others
13.5.3.2. India Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Indication
13.5.3.2.1. Pulmonary Infection
13.5.3.2.1.1. Tuberculosis
13.5.3.2.1.2. Chronic
obstructive pulmonary disease (COPD)
13.5.3.2.1.3. Cystic
fibrosis
13.5.3.2.1.4. Asthma
13.5.3.2.1.5. Others
13.5.3.2.2. Musculoskeletal Infections
13.5.3.2.2.1. Osteomyelitis
13.5.3.2.2.2. Myositis
13.5.3.2.2.3. Pyomyositis
13.5.3.2.2.4. Septic
Arthritis
13.5.3.2.2.5. Abscess
13.5.3.2.2.6. Others
13.5.3.2.3. Abdominal and Pelvic Infections
13.5.3.2.4. Neurological Infections
13.5.3.2.4.1. Encephalitis
13.5.3.2.4.2. Meningitis
13.5.3.2.4.3. Fungal
infections
13.5.3.2.4.4. Parasitic
infections
13.5.3.2.4.5. Prion
diseases
13.5.3.2.4.6. Others
13.5.3.2.5. Kidney Infections
13.5.3.2.6. Meningeal infection
13.5.3.2.7. Others
13.5.3.3. India Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Age Group
13.5.3.3.1. Pediatric
13.5.3.3.2. Adults
13.5.3.3.3. Geriatric
13.5.4. New
Zealand
13.5.4.1. New Zealand Infections Imaging Services Market Revenue (US$
Mn) and Forecasts, By Modalities
13.5.4.1.1. X-ray imaging
13.5.4.1.2. Computed Tomography (CT)
13.5.4.1.3. Magnetic Resonance Imaging (MRI
13.5.4.1.4. Ultrasound
13.5.4.1.5. Nuclear Medicine Techniques
13.5.4.1.5.1. Positron
Emission Tomography (PET)
13.5.4.1.5.2. Single-Photon
Emission Computed Tomography (SPECT)
13.5.4.1.6. Others
13.5.4.2. New Zealand Infections Imaging Services Market Revenue (US$
Mn) and Forecasts, By Indication
13.5.4.2.1. Pulmonary Infection
13.5.4.2.1.1. Tuberculosis
13.5.4.2.1.2. Chronic
obstructive pulmonary disease (COPD)
13.5.4.2.1.3. Cystic
fibrosis
13.5.4.2.1.4. Asthma
13.5.4.2.1.5. Others
13.5.4.2.2. Musculoskeletal Infections
13.5.4.2.2.1. Osteomyelitis
13.5.4.2.2.2. Myositis
13.5.4.2.2.3. Pyomyositis
13.5.4.2.2.4. Septic
Arthritis
13.5.4.2.2.5. Abscess
13.5.4.2.2.6. Others
13.5.4.2.3. Abdominal and Pelvic Infections
13.5.4.2.4. Neurological Infections
13.5.4.2.4.1. Encephalitis
13.5.4.2.4.2. Meningitis
13.5.4.2.4.3. Fungal
infections
13.5.4.2.4.4. Parasitic
infections
13.5.4.2.4.5. Prion
diseases
13.5.4.2.4.6. Others
13.5.4.2.5. Kidney Infections
13.5.4.2.6. Meningeal infection
13.5.4.2.7. Others
13.5.4.3. New Zealand Infections Imaging Services Market Revenue (US$
Mn) and Forecasts, By Age Group
13.5.4.3.1. Pediatric
13.5.4.3.2. Adults
13.5.4.3.3. Geriatric
13.5.5. Australia
13.5.5.1. Australia Infections Imaging Services Market Revenue (US$ Mn)
and Forecasts, By Modalities
13.5.5.1.1. X-ray imaging
13.5.5.1.2. Computed Tomography (CT)
13.5.5.1.3. Magnetic Resonance Imaging (MRI
13.5.5.1.4. Ultrasound
13.5.5.1.5. Nuclear Medicine Techniques
13.5.5.1.5.1. Positron
Emission Tomography (PET)
13.5.5.1.5.2. Single-Photon
Emission Computed Tomography (SPECT)
13.5.5.1.6. Others
13.5.5.2. Australia Infections Imaging Services Market Revenue (US$ Mn)
and Forecasts, By Indication
13.5.5.2.1. Pulmonary Infection
13.5.5.2.1.1. Tuberculosis
13.5.5.2.1.2. Chronic
obstructive pulmonary disease (COPD)
13.5.5.2.1.3. Cystic
fibrosis
13.5.5.2.1.4. Asthma
13.5.5.2.1.5. Others
13.5.5.2.2. Musculoskeletal Infections
13.5.5.2.2.1. Osteomyelitis
13.5.5.2.2.2. Myositis
13.5.5.2.2.3. Pyomyositis
13.5.5.2.2.4. Septic
Arthritis
13.5.5.2.2.5. Abscess
13.5.5.2.2.6. Others
13.5.5.2.3. Abdominal and Pelvic Infections
13.5.5.2.4. Neurological Infections
13.5.5.2.4.1. Encephalitis
13.5.5.2.4.2. Meningitis
13.5.5.2.4.3. Fungal
infections
13.5.5.2.4.4. Parasitic
infections
13.5.5.2.4.5. Prion
diseases
13.5.5.2.4.6. Others
13.5.5.2.5. Kidney Infections
13.5.5.2.6. Meningeal infection
13.5.5.2.7. Others
13.5.5.3. Australia Infections Imaging Services Market Revenue (US$ Mn)
and Forecasts, By Age Group
13.5.5.3.1. Pediatric
13.5.5.3.2. Adults
13.5.5.3.3. Geriatric
13.5.6. South
Korea
13.5.6.1. South Korea Infections Imaging Services Market Revenue (US$
Mn) and Forecasts, By Modalities
13.5.6.1.1. X-ray imaging
13.5.6.1.2. Computed Tomography (CT)
13.5.6.1.3. Magnetic Resonance Imaging (MRI
13.5.6.1.4. Ultrasound
13.5.6.1.5. Nuclear Medicine Techniques
13.5.6.1.5.1. Positron
Emission Tomography (PET)
13.5.6.1.5.2. Single-Photon
Emission Computed Tomography (SPECT)
13.5.6.1.6. Others
13.5.6.2. South Korea Infections Imaging Services Market Revenue (US$
Mn) and Forecasts, By Indication
13.5.6.2.1. Pulmonary Infection
13.5.6.2.1.1. Tuberculosis
13.5.6.2.1.2. Chronic
obstructive pulmonary disease (COPD)
13.5.6.2.1.3. Cystic
fibrosis
13.5.6.2.1.4. Asthma
13.5.6.2.1.5. Others
13.5.6.2.2. Musculoskeletal Infections
13.5.6.2.2.1. Osteomyelitis
13.5.6.2.2.2. Myositis
13.5.6.2.2.3. Pyomyositis
13.5.6.2.2.4. Septic
Arthritis
13.5.6.2.2.5. Abscess
13.5.6.2.2.6. Others
13.5.6.2.3. Abdominal and Pelvic Infections
13.5.6.2.4. Neurological Infections
13.5.6.2.4.1. Encephalitis
13.5.6.2.4.2. Meningitis
13.5.6.2.4.3. Fungal
infections
13.5.6.2.4.4. Parasitic
infections
13.5.6.2.4.5. Prion
diseases
13.5.6.2.4.6. Others
13.5.6.2.5. Kidney Infections
13.5.6.2.6. Meningeal infection
13.5.6.2.7. Others
13.5.6.3. South Korea Infections Imaging Services Market Revenue (US$
Mn) and Forecasts, By Age Group
13.5.6.3.1. Pediatric
13.5.6.3.2. Adults
13.5.6.3.3. Geriatric
13.5.7. Southeast
Asia
13.5.7.1. Southeast Asia Infections Imaging Services Market Revenue (US$
Mn) and Forecasts, By Modalities
13.5.7.1.1. X-ray imaging
13.5.7.1.2. Computed Tomography (CT)
13.5.7.1.3. Magnetic Resonance Imaging (MRI
13.5.7.1.4. Ultrasound
13.5.7.1.5. Nuclear Medicine Techniques
13.5.7.1.5.1. Positron
Emission Tomography (PET)
13.5.7.1.5.2. Single-Photon
Emission Computed Tomography (SPECT)
13.5.7.1.6. Others
13.5.7.2. Southeast Asia Infections Imaging Services Market Revenue (US$
Mn) and Forecasts, By Indication
13.5.7.2.1. Pulmonary Infection
13.5.7.2.1.1. Tuberculosis
13.5.7.2.1.2. Chronic
obstructive pulmonary disease (COPD)
13.5.7.2.1.3. Cystic
fibrosis
13.5.7.2.1.4. Asthma
13.5.7.2.1.5. Others
13.5.7.2.2. Musculoskeletal Infections
13.5.7.2.2.1. Osteomyelitis
13.5.7.2.2.2. Myositis
13.5.7.2.2.3. Pyomyositis
13.5.7.2.2.4. Septic
Arthritis
13.5.7.2.2.5. Abscess
13.5.7.2.2.6. Others
13.5.7.2.3. Abdominal and Pelvic Infections
13.5.7.2.4. Neurological Infections
13.5.7.2.4.1. Encephalitis
13.5.7.2.4.2. Meningitis
13.5.7.2.4.3. Fungal
infections
13.5.7.2.4.4. Parasitic
infections
13.5.7.2.4.5. Prion
diseases
13.5.7.2.4.6. Others
13.5.7.2.5. Kidney Infections
13.5.7.2.6. Meningeal infection
13.5.7.2.7. Others
13.5.7.3. Southeast Asia Infections Imaging Services Market Revenue (US$
Mn) and Forecasts, By Age Group
13.5.7.3.1. Pediatric
13.5.7.3.2. Adults
13.5.7.3.3. Geriatric
13.5.7.4. Southeast Asia Infections Imaging Services Market Revenue (US$
Mn) and Forecasts, By Country
13.5.7.4.1. Indonesia
13.5.7.4.2. Thailand
13.5.7.4.3. Malaysia
13.5.7.4.4. Singapore
13.5.7.4.5. Rest of Southeast Asia
13.5.8. Rest of
Asia Pacific
13.5.8.1. Rest of Asia Pacific Infections Imaging Services Market
Revenue (US$ Mn) and Forecasts, By Modalities
13.5.8.1.1. X-ray imaging
13.5.8.1.2. Computed Tomography (CT)
13.5.8.1.3. Magnetic Resonance Imaging (MRI
13.5.8.1.4. Ultrasound
13.5.8.1.5. Nuclear Medicine Techniques
13.5.8.1.5.1. Positron
Emission Tomography (PET)
13.5.8.1.5.2. Single-Photon
Emission Computed Tomography (SPECT)
13.5.8.1.6. Others
13.5.8.2. Rest of Asia Pacific Infections Imaging Services Market
Revenue (US$ Mn) and Forecasts, By Indication
13.5.8.2.1. Pulmonary Infection
13.5.8.2.1.1. Tuberculosis
13.5.8.2.1.2. Chronic
obstructive pulmonary disease (COPD)
13.5.8.2.1.3. Cystic
fibrosis
13.5.8.2.1.4. Asthma
13.5.8.2.1.5. Others
13.5.8.2.2. Musculoskeletal Infections
13.5.8.2.2.1. Osteomyelitis
13.5.8.2.2.2. Myositis
13.5.8.2.2.3. Pyomyositis
13.5.8.2.2.4. Septic
Arthritis
13.5.8.2.2.5. Abscess
13.5.8.2.2.6. Others
13.5.8.2.3. Abdominal and Pelvic Infections
13.5.8.2.4. Neurological Infections
13.5.8.2.4.1. Encephalitis
13.5.8.2.4.2. Meningitis
13.5.8.2.4.3. Fungal
infections
13.5.8.2.4.4. Parasitic
infections
13.5.8.2.4.5. Prion
diseases
13.5.8.2.4.6. Others
13.5.8.2.5. Kidney Infections
13.5.8.2.6. Meningeal infection
13.5.8.2.7. Others
13.5.8.3. Rest of Asia Pacific Infections Imaging Services Market
Revenue (US$ Mn) and Forecasts, By Age Group
13.5.8.3.1. Pediatric
13.5.8.3.2. Adults
13.5.8.3.3. Geriatric
13.6. Key
Segment for Channeling Investments
13.6.1. By
Country
13.6.2. By
Modalities
13.6.3. By
Indication
13.6.4. By Age
Group
14. Middle East and Africa Infections Imaging Services Market
Analysis and Forecasts, 2023 - 2031
14.1. Overview
14.1.1. Middle
East and Africa Infections Imaging Services Market Revenue (US$ Mn)
14.2. Middle
East and Africa Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Modalities
14.2.1. X-ray
imaging
14.2.2. Computed
Tomography (CT)
14.2.3. Magnetic
Resonance Imaging (MRI
14.2.4. Ultrasound
14.2.5. Nuclear
Medicine Techniques
14.2.5.1. Positron Emission Tomography (PET)
14.2.5.2. Single-Photon Emission Computed Tomography (SPECT)
14.2.6. Others
14.3. Middle
East and Africa Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Indication
14.3.1. Pulmonary
Infection
14.3.1.1. Tuberculosis
14.3.1.2. Chronic obstructive pulmonary disease (COPD)
14.3.1.3. Cystic fibrosis
14.3.1.4. Asthma
14.3.1.5. Others
14.3.2. Musculoskeletal
Infections
14.3.2.1. Osteomyelitis
14.3.2.2. Myositis
14.3.2.3. Pyomyositis
14.3.2.4. Septic Arthritis
14.3.2.5. Abscess
14.3.2.6. Others
14.3.3. Abdominal
and Pelvic Infections
14.3.4. Neurological
Infections
14.3.4.1. Encephalitis
14.3.4.2. Meningitis
14.3.4.3. Fungal infections
14.3.4.4. Parasitic infections
14.3.4.5. Prion diseases
14.3.4.6. Others
14.3.5. Kidney
Infections
14.3.6. Meningeal
infection
14.3.7. Others
14.4. Middle
East and Africa Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Age Group
14.4.1. Pediatric
14.4.2. Adults
14.4.3. Geriatric
14.5. Middle
East and Africa Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Country
14.5.1. Saudi
Arabia
14.5.1.1. Saudi Arabia Infections Imaging Services Market Revenue (US$
Mn) and Forecasts, By Modalities
14.5.1.1.1. X-ray imaging
14.5.1.1.2. Computed Tomography (CT)
14.5.1.1.3. Magnetic Resonance Imaging (MRI
14.5.1.1.4. Ultrasound
14.5.1.1.5. Nuclear Medicine Techniques
14.5.1.1.5.1. Positron
Emission Tomography (PET)
14.5.1.1.5.2. Single-Photon
Emission Computed Tomography (SPECT)
14.5.1.1.6. Others
14.5.1.2. Saudi Arabia Infections Imaging Services Market Revenue (US$
Mn) and Forecasts, By Indication
14.5.1.2.1. Pulmonary Infection
14.5.1.2.1.1. Tuberculosis
14.5.1.2.1.2. Chronic
obstructive pulmonary disease (COPD)
14.5.1.2.1.3. Cystic
fibrosis
14.5.1.2.1.4. Asthma
14.5.1.2.1.5. Others
14.5.1.2.2. Musculoskeletal Infections
14.5.1.2.2.1. Osteomyelitis
14.5.1.2.2.2. Myositis
14.5.1.2.2.3. Pyomyositis
14.5.1.2.2.4. Septic
Arthritis
14.5.1.2.2.5. Abscess
14.5.1.2.2.6. Others
14.5.1.2.3. Abdominal and Pelvic Infections
14.5.1.2.4. Neurological Infections
14.5.1.2.4.1. Encephalitis
14.5.1.2.4.2. Meningitis
14.5.1.2.4.3. Fungal
infections
14.5.1.2.4.4. Parasitic
infections
14.5.1.2.4.5. Prion
diseases
14.5.1.2.4.6. Others
14.5.1.2.5. Kidney Infections
14.5.1.2.6. Meningeal infection
14.5.1.2.7. Others
14.5.1.3. Saudi Arabia Infections Imaging Services Market Revenue (US$
Mn) and Forecasts, By Age Group
14.5.1.3.1. Pediatric
14.5.1.3.2. Adults
14.5.1.3.3. Geriatric
14.5.2. UAE
14.5.2.1. UAE Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Modalities
14.5.2.1.1. X-ray imaging
14.5.2.1.2. Computed Tomography (CT)
14.5.2.1.3. Magnetic Resonance Imaging (MRI
14.5.2.1.4. Ultrasound
14.5.2.1.5. Nuclear Medicine Techniques
14.5.2.1.5.1. Positron
Emission Tomography (PET)
14.5.2.1.5.2. Single-Photon
Emission Computed Tomography (SPECT)
14.5.2.1.6. Others
14.5.2.2. UAE Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Indication
14.5.2.2.1. Pulmonary Infection
14.5.2.2.1.1. Tuberculosis
14.5.2.2.1.2. Chronic
obstructive pulmonary disease (COPD)
14.5.2.2.1.3. Cystic
fibrosis
14.5.2.2.1.4. Asthma
14.5.2.2.1.5. Others
14.5.2.2.2. Musculoskeletal Infections
14.5.2.2.2.1. Osteomyelitis
14.5.2.2.2.2. Myositis
14.5.2.2.2.3. Pyomyositis
14.5.2.2.2.4. Septic
Arthritis
14.5.2.2.2.5. Abscess
14.5.2.2.2.6. Others
14.5.2.2.3. Abdominal and Pelvic Infections
14.5.2.2.4. Neurological Infections
14.5.2.2.4.1. Encephalitis
14.5.2.2.4.2. Meningitis
14.5.2.2.4.3. Fungal
infections
14.5.2.2.4.4. Parasitic
infections
14.5.2.2.4.5. Prion
diseases
14.5.2.2.4.6. Others
14.5.2.2.5. Kidney Infections
14.5.2.2.6. Meningeal infection
14.5.2.2.7. Others
14.5.2.3. UAE Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Age Group
14.5.2.3.1. Pediatric
14.5.2.3.2. Adults
14.5.2.3.3. Geriatric
14.5.3. Egypt
14.5.3.1. Egypt Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Modalities
14.5.3.1.1. X-ray imaging
14.5.3.1.2. Computed Tomography (CT)
14.5.3.1.3. Magnetic Resonance Imaging (MRI
14.5.3.1.4. Ultrasound
14.5.3.1.5. Nuclear Medicine Techniques
14.5.3.1.5.1. Positron
Emission Tomography (PET)
14.5.3.1.5.2. Single-Photon
Emission Computed Tomography (SPECT)
14.5.3.1.6. Others
14.5.3.2. Egypt Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Indication
14.5.3.2.1. Pulmonary Infection
14.5.3.2.1.1. Tuberculosis
14.5.3.2.1.2. Chronic
obstructive pulmonary disease (COPD)
14.5.3.2.1.3. Cystic
fibrosis
14.5.3.2.1.4. Asthma
14.5.3.2.1.5. Others
14.5.3.2.2. Musculoskeletal Infections
14.5.3.2.2.1. Osteomyelitis
14.5.3.2.2.2. Myositis
14.5.3.2.2.3. Pyomyositis
14.5.3.2.2.4. Septic
Arthritis
14.5.3.2.2.5. Abscess
14.5.3.2.2.6. Others
14.5.3.2.3. Abdominal and Pelvic Infections
14.5.3.2.4. Neurological Infections
14.5.3.2.4.1. Encephalitis
14.5.3.2.4.2. Meningitis
14.5.3.2.4.3. Fungal
infections
14.5.3.2.4.4. Parasitic
infections
14.5.3.2.4.5. Prion
diseases
14.5.3.2.4.6. Others
14.5.3.2.5. Kidney Infections
14.5.3.2.6. Meningeal infection
14.5.3.2.7. Others
14.5.3.3. Egypt Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Age Group
14.5.3.3.1. Pediatric
14.5.3.3.2. Adults
14.5.3.3.3. Geriatric
14.5.4. Kuwait
14.5.4.1. Kuwait Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Modalities
14.5.4.1.1. X-ray imaging
14.5.4.1.2. Computed Tomography (CT)
14.5.4.1.3. Magnetic Resonance Imaging (MRI
14.5.4.1.4. Ultrasound
14.5.4.1.5. Nuclear Medicine Techniques
14.5.4.1.5.1. Positron
Emission Tomography (PET)
14.5.4.1.5.2. Single-Photon
Emission Computed Tomography (SPECT)
14.5.4.1.6. Others
14.5.4.2. Kuwait Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Indication
14.5.4.2.1. Pulmonary Infection
14.5.4.2.1.1. Tuberculosis
14.5.4.2.1.2. Chronic
obstructive pulmonary disease (COPD)
14.5.4.2.1.3. Cystic
fibrosis
14.5.4.2.1.4. Asthma
14.5.4.2.1.5. Others
14.5.4.2.2. Musculoskeletal Infections
14.5.4.2.2.1. Osteomyelitis
14.5.4.2.2.2. Myositis
14.5.4.2.2.3. Pyomyositis
14.5.4.2.2.4. Septic
Arthritis
14.5.4.2.2.5. Abscess
14.5.4.2.2.6. Others
14.5.4.2.3. Abdominal and Pelvic Infections
14.5.4.2.4. Neurological Infections
14.5.4.2.4.1. Encephalitis
14.5.4.2.4.2. Meningitis
14.5.4.2.4.3. Fungal
infections
14.5.4.2.4.4. Parasitic
infections
14.5.4.2.4.5. Prion
diseases
14.5.4.2.4.6. Others
14.5.4.2.5. Kidney Infections
14.5.4.2.6. Meningeal infection
14.5.4.2.7. Others
14.5.4.3. Kuwait Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Age Group
14.5.4.3.1. Pediatric
14.5.4.3.2. Adults
14.5.4.3.3. Geriatric
14.5.5. South
Africa
14.5.5.1. South Africa Infections Imaging Services Market Revenue (US$
Mn) and Forecasts, By Modalities
14.5.5.1.1. X-ray imaging
14.5.5.1.2. Computed Tomography (CT)
14.5.5.1.3. Magnetic Resonance Imaging (MRI
14.5.5.1.4. Ultrasound
14.5.5.1.5. Nuclear Medicine Techniques
14.5.5.1.5.1. Positron
Emission Tomography (PET)
14.5.5.1.5.2. Single-Photon
Emission Computed Tomography (SPECT)
14.5.5.1.6. Others
14.5.5.2. South Africa Infections Imaging Services Market Revenue (US$
Mn) and Forecasts, By Indication
14.5.5.2.1. Pulmonary Infection
14.5.5.2.1.1. Tuberculosis
14.5.5.2.1.2. Chronic
obstructive pulmonary disease (COPD)
14.5.5.2.1.3. Cystic
fibrosis
14.5.5.2.1.4. Asthma
14.5.5.2.1.5. Others
14.5.5.2.2. Musculoskeletal Infections
14.5.5.2.2.1. Osteomyelitis
14.5.5.2.2.2. Myositis
14.5.5.2.2.3. Pyomyositis
14.5.5.2.2.4. Septic
Arthritis
14.5.5.2.2.5. Abscess
14.5.5.2.2.6. Others
14.5.5.2.3. Abdominal and Pelvic Infections
14.5.5.2.4. Neurological Infections
14.5.5.2.4.1. Encephalitis
14.5.5.2.4.2. Meningitis
14.5.5.2.4.3. Fungal
infections
14.5.5.2.4.4. Parasitic
infections
14.5.5.2.4.5. Prion
diseases
14.5.5.2.4.6. Others
14.5.5.2.5. Kidney Infections
14.5.5.2.6. Meningeal infection
14.5.5.2.7. Others
14.5.5.3. South Africa Infections Imaging Services Market Revenue (US$
Mn) and Forecasts, By Age Group
14.5.5.3.1. Pediatric
14.5.5.3.2. Adults
14.5.5.3.3. Geriatric
14.5.6. Rest of
Middle East & Africa
14.5.6.1. Rest of Middle East & Africa Infections Imaging Services
Market Revenue (US$ Mn) and Forecasts, By Modalities
14.5.6.1.1. X-ray imaging
14.5.6.1.2. Computed Tomography (CT)
14.5.6.1.3. Magnetic Resonance Imaging (MRI
14.5.6.1.4. Ultrasound
14.5.6.1.5. Nuclear Medicine Techniques
14.5.6.1.5.1. Positron
Emission Tomography (PET)
14.5.6.1.5.2. Single-Photon
Emission Computed Tomography (SPECT)
14.5.6.1.6. Others
14.5.6.2. Rest of Middle East & Africa Infections Imaging Services
Market Revenue (US$ Mn) and Forecasts, By Indication
14.5.6.2.1. Pulmonary Infection
14.5.6.2.1.1. Tuberculosis
14.5.6.2.1.2. Chronic
obstructive pulmonary disease (COPD)
14.5.6.2.1.3. Cystic
fibrosis
14.5.6.2.1.4. Asthma
14.5.6.2.1.5. Others
14.5.6.2.2. Musculoskeletal Infections
14.5.6.2.2.1. Osteomyelitis
14.5.6.2.2.2. Myositis
14.5.6.2.2.3. Pyomyositis
14.5.6.2.2.4. Septic
Arthritis
14.5.6.2.2.5. Abscess
14.5.6.2.2.6. Others
14.5.6.2.3. Abdominal and Pelvic Infections
14.5.6.2.4. Neurological Infections
14.5.6.2.4.1. Encephalitis
14.5.6.2.4.2. Meningitis
14.5.6.2.4.3. Fungal
infections
14.5.6.2.4.4. Parasitic
infections
14.5.6.2.4.5. Prion
diseases
14.5.6.2.4.6. Others
14.5.6.2.5. Kidney Infections
14.5.6.2.6. Meningeal infection
14.5.6.2.7. Others
14.5.6.3. Rest of Middle East & Africa Infections Imaging Services
Market Revenue (US$ Mn) and Forecasts, By Age Group
14.5.6.3.1. Pediatric
14.5.6.3.2. Adults
14.5.6.3.3. Geriatric
14.6. Key
Segment for Channeling Investments
14.6.1. By
Country
14.6.2. By
Modalities
14.6.3. By
Indication
14.6.4. By Age
Group
15. Latin America Infections Imaging Services Market Analysis and
Forecasts, 2023 - 2031
15.1. Overview
15.1.1. Latin
America Infections Imaging Services Market Revenue (US$ Mn)
15.2. Latin
America Infections Imaging Services Market Revenue (US$ Mn) and Forecasts, By
Modalities
15.2.1. X-ray
imaging
15.2.2. Computed
Tomography (CT)
15.2.3. Magnetic
Resonance Imaging (MRI
15.2.4. Ultrasound
15.2.5. Nuclear
Medicine Techniques
15.2.5.1. Positron Emission Tomography (PET)
15.2.5.2. Single-Photon Emission Computed Tomography (SPECT)
15.2.6. Others
15.3. Latin
America Infections Imaging Services Market Revenue (US$ Mn) and Forecasts, By
Indication
15.3.1. Pulmonary
Infection
15.3.1.1. Tuberculosis
15.3.1.2. Chronic obstructive pulmonary disease (COPD)
15.3.1.3. Cystic fibrosis
15.3.1.4. Asthma
15.3.1.5. Others
15.3.2. Musculoskeletal
Infections
15.3.2.1. Osteomyelitis
15.3.2.2. Myositis
15.3.2.3. Pyomyositis
15.3.2.4. Septic Arthritis
15.3.2.5. Abscess
15.3.2.6. Others
15.3.3. Abdominal
and Pelvic Infections
15.3.4. Neurological
Infections
15.3.4.1. Encephalitis
15.3.4.2. Meningitis
15.3.4.3. Fungal infections
15.3.4.4. Parasitic infections
15.3.4.5. Prion diseases
15.3.4.6. Others
15.3.5. Kidney
Infections
15.3.6. Meningeal
infection
15.3.7. Others
15.4. Latin
America Infections Imaging Services Market Revenue (US$ Mn) and Forecasts, By
Age Group
15.4.1. Pediatric
15.4.2. Adults
15.4.3. Geriatric
15.5. Latin
America Infections Imaging Services Market Revenue (US$ Mn) and Forecasts, By
Country
15.5.1. Brazil
15.5.1.1. Brazil Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Modalities
15.5.1.1.1. X-ray imaging
15.5.1.1.2. Computed Tomography (CT)
15.5.1.1.3. Magnetic Resonance Imaging (MRI
15.5.1.1.4. Ultrasound
15.5.1.1.5. Nuclear Medicine Techniques
15.5.1.1.5.1. Positron
Emission Tomography (PET)
15.5.1.1.5.2. Single-Photon
Emission Computed Tomography (SPECT)
15.5.1.1.6. Others
15.5.1.2. Brazil Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Indication
15.5.1.2.1. Pulmonary Infection
15.5.1.2.1.1. Tuberculosis
15.5.1.2.1.2. Chronic
obstructive pulmonary disease (COPD)
15.5.1.2.1.3. Cystic
fibrosis
15.5.1.2.1.4. Asthma
15.5.1.2.1.5. Others
15.5.1.2.2. Musculoskeletal Infections
15.5.1.2.2.1. Osteomyelitis
15.5.1.2.2.2. Myositis
15.5.1.2.2.3. Pyomyositis
15.5.1.2.2.4. Septic
Arthritis
15.5.1.2.2.5. Abscess
15.5.1.2.2.6. Others
15.5.1.2.3. Abdominal and Pelvic Infections
15.5.1.2.4. Neurological Infections
15.5.1.2.4.1. Encephalitis
15.5.1.2.4.2. Meningitis
15.5.1.2.4.3. Fungal
infections
15.5.1.2.4.4. Parasitic
infections
15.5.1.2.4.5. Prion
diseases
15.5.1.2.4.6. Others
15.5.1.2.5. Kidney Infections
15.5.1.2.6. Meningeal infection
15.5.1.2.7. Others
15.5.1.3. Brazil Infections Imaging Services Market Revenue (US$ Mn) and
Forecasts, By Age Group
15.5.1.3.1. Pediatric
15.5.1.3.2. Adults
15.5.1.3.3. Geriatric
15.5.2. Argentina
15.5.2.1. Argentina Infections Imaging Services Market Revenue (US$ Mn)
and Forecasts, By Modalities
15.5.2.1.1. X-ray imaging
15.5.2.1.2. Computed Tomography (CT)
15.5.2.1.3. Magnetic Resonance Imaging (MRI
15.5.2.1.4. Ultrasound
15.5.2.1.5. Nuclear Medicine Techniques
15.5.2.1.5.1. Positron
Emission Tomography (PET)
15.5.2.1.5.2. Single-Photon
Emission Computed Tomography (SPECT)
15.5.2.1.6. Others
15.5.2.2. Argentina Infections Imaging Services Market Revenue (US$ Mn)
and Forecasts, By Indication
15.5.2.2.1. Pulmonary Infection
15.5.2.2.1.1. Tuberculosis
15.5.2.2.1.2. Chronic
obstructive pulmonary disease (COPD)
15.5.2.2.1.3. Cystic
fibrosis
15.5.2.2.1.4. Asthma
15.5.2.2.1.5. Others
15.5.2.2.2. Musculoskeletal Infections
15.5.2.2.2.1. Osteomyelitis
15.5.2.2.2.2. Myositis
15.5.2.2.2.3. Pyomyositis
15.5.2.2.2.4. Septic
Arthritis
15.5.2.2.2.5. Abscess
15.5.2.2.2.6. Others
15.5.2.2.3. Abdominal and Pelvic Infections
15.5.2.2.4. Neurological Infections
15.5.2.2.4.1. Encephalitis
15.5.2.2.4.2. Meningitis
15.5.2.2.4.3. Fungal
infections
15.5.2.2.4.4. Parasitic
infections
15.5.2.2.4.5. Prion
diseases
15.5.2.2.4.6. Others
15.5.2.2.5. Kidney Infections
15.5.2.2.6. Meningeal infection
15.5.2.2.7. Others
15.5.2.3. Argentina Infections Imaging Services Market Revenue (US$ Mn)
and Forecasts, By Age Group
15.5.2.3.1. Pediatric
15.5.2.3.2. Adults
15.5.2.3.3. Geriatric
15.5.3. Rest of
Latin America
15.5.3.1. Rest of Latin America Infections Imaging Services Market
Revenue (US$ Mn) and Forecasts, By Modalities
15.5.3.1.1. X-ray imaging
15.5.3.1.2. Computed Tomography (CT)
15.5.3.1.3. Magnetic Resonance Imaging (MRI
15.5.3.1.4. Ultrasound
15.5.3.1.5. Nuclear Medicine Techniques
15.5.3.1.5.1. Positron
Emission Tomography (PET)
15.5.3.1.5.2. Single-Photon
Emission Computed Tomography (SPECT)
15.5.3.1.6. Others
15.5.3.2. Rest of Latin America Infections Imaging Services Market
Revenue (US$ Mn) and Forecasts, By Indication
15.5.3.2.1. Pulmonary Infection
15.5.3.2.1.1. Tuberculosis
15.5.3.2.1.2. Chronic
obstructive pulmonary disease (COPD)
15.5.3.2.1.3. Cystic
fibrosis
15.5.3.2.1.4. Asthma
15.5.3.2.1.5. Others
15.5.3.2.2. Musculoskeletal Infections
15.5.3.2.2.1. Osteomyelitis
15.5.3.2.2.2. Myositis
15.5.3.2.2.3. Pyomyositis
15.5.3.2.2.4. Septic
Arthritis
15.5.3.2.2.5. Abscess
15.5.3.2.2.6. Others
15.5.3.2.3. Abdominal and Pelvic Infections
15.5.3.2.4. Neurological Infections
15.5.3.2.4.1. Encephalitis
15.5.3.2.4.2. Meningitis
15.5.3.2.4.3. Fungal
infections
15.5.3.2.4.4. Parasitic
infections
15.5.3.2.4.5. Prion
diseases
15.5.3.2.4.6. Others
15.5.3.2.5. Kidney Infections
15.5.3.2.6. Meningeal infection
15.5.3.2.7. Others
15.5.3.3. Rest of Latin America Infections Imaging Services Market
Revenue (US$ Mn) and Forecasts, By Age Group
15.5.3.3.1. Pediatric
15.5.3.3.2. Adults
15.5.3.3.3. Geriatric
15.6. Key
Segment for Channeling Investments
15.6.1. By
Country
15.6.2. By
Modalities
15.6.3. By
Indication
15.6.4. By Age
Group
16. Competitive Benchmarking
16.1. Market
Share Analysis, 2022
16.2. Global
Presence and Growth Strategies
16.2.1. Mergers
and Acquisitions
16.2.2. Product
Launches
16.2.3. Investments
Trends
16.2.4. R&D
Initiatives
17. Player Profiles
17.1. Agiliti
Health, Inc
17.1.1. Company
Details
17.1.2. Company
Overview
17.1.3. Product
Offerings
17.1.4. Key
Developments
17.1.5. Financial
Analysis
17.1.6. SWOT
Analysis
17.1.7. Business
Strategies
17.2. Akumin
Inc
17.2.1. Company
Details
17.2.2. Company
Overview
17.2.3. Product
Offerings
17.2.4. Key
Developments
17.2.5. Financial
Analysis
17.2.6. SWOT
Analysis
17.2.7. Business
Strategies
17.3. Alliance
MRI
17.3.1. Company
Details
17.3.2. Company
Overview
17.3.3. Product
Offerings
17.3.4. Key
Developments
17.3.5. Financial
Analysis
17.3.6. SWOT
Analysis
17.3.7. Business
Strategies
17.4. CMS
Diagnostic Services
17.4.1. Company
Details
17.4.2. Company
Overview
17.4.3. Product
Offerings
17.4.4. Key
Developments
17.4.5. Financial
Analysis
17.4.6. SWOT
Analysis
17.4.7. Business
Strategies
17.5. InHealth
Group
17.5.1. Company
Details
17.5.2. Company
Overview
17.5.3. Product
Offerings
17.5.4. Key
Developments
17.5.5. Financial
Analysis
17.5.6. SWOT
Analysis
17.5.7. Business
Strategies
17.6. RadNet,
Inc.
17.6.1. Company
Details
17.6.2. Company
Overview
17.6.3. Product
Offerings
17.6.4. Key
Developments
17.6.5. Financial
Analysis
17.6.6. SWOT
Analysis
17.6.7. Business
Strategies
17.7. RAYUS
Radiology
17.7.1. Company
Details
17.7.2. Company
Overview
17.7.3. Product
Offerings
17.7.4. Key
Developments
17.7.5. Financial
Analysis
17.7.6. SWOT
Analysis
17.7.7. Business
Strategies
17.8. SimonMed
17.8.1. Company
Details
17.8.2. Company
Overview
17.8.3. Product
Offerings
17.8.4. Key
Developments
17.8.5. Financial
Analysis
17.8.6. SWOT Analysis
17.8.7. Business
Strategies
17.9. Sonic
Healthcare Limited
17.9.1. Company
Details
17.9.2. Company
Overview
17.9.3. Product
Offerings
17.9.4. Key
Developments
17.9.5. Financial
Analysis
17.9.6. SWOT
Analysis
17.9.7. Business
Strategies
17.10. UNILABS
17.10.1. Company
Details
17.10.2. Company
Overview
17.10.3. Product
Offerings
17.10.4. Key
Developments
17.10.5. Financial
Analysis
17.10.6. SWOT
Analysis
17.10.7. Business Strategies
17.11. Other
market participants
18. Key Findings
**Exclusive for Multi-User and Enterprise User.
At Absolute Markets Insights, we are engaged in building both global as well as country specific reports. As a result, the approach taken for deriving the estimation and forecast for a specific country is a bit unique and different in comparison to the global research studies. In this case, we not only study the concerned market factors & trends prevailing in a particular country (from secondary research) but we also tend to calculate the actual market size & forecast from the revenue generated from the market participants involved in manufacturing or distributing the any concerned product. These companies can also be service providers. For analyzing any country specifically, we do consider the growth factors prevailing under the states/cities/county for the same. For instance, if we are analyzing an industry specific to United States, we primarily need to study about the states present under the same(where the product/service has the highest growth). Similar analysis will be followed by other countries. Our scope of the report changes with different markets.
Our research study is mainly implement through a mix of both secondary and primary research. Various sources such as industry magazines, trade journals, and government websites and trade associations are reviewed for gathering precise data. Primary interviews are conducted to validate the market size derived from secondary research. Industry experts, major manufacturers and distributors are contacted for further validation purpose on the current market penetration and growth trends.
Prominent participants in our primary research process include:
- Key Opinion Leaders namely the CEOs, CSOs, VPs, purchasing managers, amongst others
- Research and development participants, distributors/suppliers and subject matter experts
Secondary Research includes data extracted from paid data sources:
- Reuters
- Factiva
- Bloomberg
- One Source
- Hoovers
Research Methodology
Key Inclusions
Reach to us
Call us on
+91-74002-42424
Drop us an email at
sales@absolutemarketsinsights.com
Why Absolute Markets Insights?
An effective strategy is the entity that influences a business to stand out of the crowd. An organization with a phenomenal strategy for success dependably has the edge over the rivals in the market. It offers the organizations a head start in planning their strategy. Absolute Market Insights is the new initiation in the industry that will furnish you with the lead your business needs. Absolute Market Insights is the best destination for your business intelligence and analytical solutions; essentially because our qualitative and quantitative sources of information are competent to give one-stop solutions. We inventively combine qualitative and quantitative research in accurate proportions to have the best report, which not only gives the most recent insights but also assists you to grow.